Introduction The coronavirus pandemic has affected more than 20 million people so far.
Elevated cytokines and suppressed immune responses have been hypothesized to set off a …

Abstract Coronavirus disease 2019 (COVID‐19) is caused by SARS‐CoV‐2, a novel
coronavirus strain. Some studies suggest that COVID‐19 could be an immune‐related …

The new respiratory infectious disease coronavirus disease 2019 (COVID-19) that
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19,
which has affected more than 6 million people worldwide causing more than 400 000 …

Background Coronavirus disease once thought to be a respiratory infection is now
recognised as a multi-system disease affecting the respiratory, cardiovascular …

COVID-19 caused by the SARS-CoV-2 virus, accompanies an unprecedented spike in
cytokines levels termed cytokines release syndrome (CRS), in critically ill patients. Clinicians …

This study involves the histological analysis of samples taken during autopsies in cases of
COVID-19 related death to evaluate the inflammatory cytokine response and the tissue …

Background: Coagulopathy and thromboembolic events are common in Covid‐19 patients
and are poor prognostic factors. Controversy exists regarding the potential of …

The novel coronavirus, SARS-CoV-2, rapidly spread worldwide, causing an ongoing global
pandemic. While the respiratory system is the most common site of infection, a significant …

Background: The SARS-CoV-2 pandemic has become an enormous worldwide challenge
over the last two years. However, little is still known about the risk of Long COVID (LC) in …